Transgenic rabbit models to investigate the cardiac ion channel disease long QT syndrome

Progress in Biophysics and Molecular Biology

Volumn 121, Issue 2, 2016, Pages 142-156

  Lang, C N ^a,b   Koren, G ^c   Odening, K E ^a,b  

^a UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c BROWN UNIVERSITY   (United States)

Author keywords

Cardiac repolarization; Long QT syndrome; Transgenic animal model; Ventricular arrhythmia

Indexed keywords

ION CHANNEL;

ANIMAL; DISEASE MODEL; GENETICS; HUMAN; LONG QT SYNDROME; METABOLISM; PATHOPHYSIOLOGY; RABBIT; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; DISEASE MODELS, ANIMAL; HUMANS; ION CHANNELS; LONG QT SYNDROME; RABBITS;

EID: 84969677244     PISSN: 00796107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbiomolbio.2016.05.004     Document Type: Review

References (141)

1. Ando, F., Kuruma, A., Kawano, S., Synergic effects of β-estradiol and erythromycin on hERG currents. J. Membr. Biol. 241 (2011), 31–38, 10.1007/s00232-011-9360-z.
2. Anneken, L., Baumann, S., Vigneault, P., Biliczki, P., Friedrich, C., Xiao, L., Girmatsion, Z., Takac, I., Brandes, R.P., Kissler, S., Wiegratz, I., Zumhagen, S., Stallmeyer, B., Hohnloser, S.H., Klingenheben, T., Schulze-Bahr, E., Nattel, S., Ehrlich, J.R., Estradiol regulates human QT-interval: acceleration of cardiac repolarization by enhanced KCNH2 membrane trafficking. Eur. Heart J., ehv371, 2015, 10.1093/eurheartj/ehv371.
3. Antzelevitch, C., Role of spatial dispersion of repolarization in inherited and acquired sudden cardiac death syndromes. Am. J. Physiol. Heart Circ. Physiol. 293 (2007), H2024–H2038, 10.1152/ajpheart.00355.2007.
4. Antzelevitch, C., Cardiac repolarization. The long and short of it. Europace 7 (2005), S3–S9, 10.1016/j.eupc.2005.05.010.
5. Babij, P., Askew, G.R., Nieuwenhuijsen, B., Su, C.M., Bridal, T.R., Jow, B., Argentieri, T.M., Kulik, J., DeGennaro, L.J., Spinelli, W., Colatsky, T.J., Inhibition of cardiac delayed rectifier K+ current by overexpression of the long-QT syndrome HERG G628S mutation in transgenic mice. Circulation Res. 83 (1998), 668–678.
6. Baczkó, I., Jost, N., Virag, L., Odening, K.E., Bodrogi, L., Hipiri, L., Varro, A., Rabbit models as tools for preclinical cardiac electrophysiological safety testing: importance of repolarization reserve. Prog. Biophys. Mol. Biol. 121:2 (2016), 157–168.
7. Barry, D.M., Xu, H., Schuessler, R.B., Nerbonne, J.M., Functional knockout of the transient outward current, long-QT syndrome, and cardiac remodeling in mice expressing a dominant-negative Kv4 alpha subunit. Circ. Res. 83 (1998), 560–567.
8. Bassani, R.A., Transient outward potassium current and Ca2+ homeostasis in the heart: beyond the action potential. Braz. J. Med. Biol. Res. 39 (2006), 393–403.
9. Baumgartner, C., Brandl, J., Münch, G., Ungerer, M., Rabbit models to study atherosclerosis and its complications – transgenic vascular protein expression in vivo. Prog Biophys Mol Biol 121/2 (2016), 131–141.
10. Ben Caref, E., Boutjdir, M., Himel, H.D., El-Sherif, N., Role of subendocardial Purkinje network in triggering torsade de pointes arrhythmia in experimental long QT syndrome. Europace 10 (2008), 1218–1223, 10.1093/europace/eun248.
11. Bentzen, B.H., Bahrke, S., Wu, K., Larsen, A.P., Odening, K.E., Franke, G., Storm vańs Gravesande, K., Biermann, J., Peng, X., Koren, G., Zehender, M., Bode, C., Grunnet, M., Brunner, M., Pharmacological activation of Kv11.1 in transgenic long QT-1 rabbits. J. Cardiovasc. Pharmacol. 57 (2011), 223–230, 10.1097/FJC.0b013e318203a44d.
12. Berger, R.D., QT variability. J. Electrocardiol. 36:Suppl. l (2003), 83–87.
13. Bers, D.M., Calcium cycling and signaling in cardiac myocytes. Annu. Rev. Physiol. 70 (2008), 23–49, 10.1146/annurev.physiol.70.113006.100455.
14. Bidoggia, H., Maciel, J.P., Capalozza, N., Mosca, S., Blaksley, E.J., Valverde, E., Bertran, G., Arini, P., Biagetti, M.O., Quinteiro, R.A., Sex-dependent electrocardiographic pattern of cardiac repolarization. Am. Heart J. 140 (2000), 430–436, 10.1067/mhj.2000.108510.
15. Biermann, J., Wu, K., Odening, K.E., Asbach, S., Koren, G., Peng, X., Zehender, M., Bode, C., Brunner, M., Nicorandil normalizes prolonged repolarisation in the first transgenic rabbit model with Long-QT syndrome 1 both in vitro and in vivo. Eur. J. Pharmacol. 650 (2011), 309–316, 10.1016/j.ejphar.2010.10.016.
16. Bosze, Z., Major, P., Baczkó, I., Odening, K.E., Bodrogi, L., Hipiri, L., Varro, A., The potential impact of new generation transgenic methods on creating rabbit models of cardiac diseases. Prog Biophys Mol Biol 121/2 (2016), 123–130.
17. Brunner, M., Guo, W., Mitchell, G.F., Buckett, P.D., Nerbonne, J.M., Koren, G., Characterization of mice with a combined suppression of I(to) and I(K,slow). Am. J. Physiol. Heart Circ. Physiol. 281 (2001), H1201–H1209.
18. Brunner, M., Kodirov, S.A., Mitchell, G.F., Buckett, P.D., Shibata, K., Folco, E.J., Baker, L., Salama, G., Chan, D.P., Zhou, J., Koren, G., In vivo gene transfer of Kv1.5 normalizes action potential duration and shortens QT interval in mice with long QT phenotype. Am. J. Physiol. Heart Circ. Physiol. 285 (2003), H194–H203, 10.1152/ajpheart.00971.2002.
19. Brunner, M., Peng, X., Liu, G.X., Ren, X.-Q., Ziv, O., Choi, B.-R., Mathur, R., Hajjiri, M., Odening, K.E., Steinberg, E., Folco, E.J., Pringa, E., Centracchio, J., Macharzina, R.R., Donahay, T., Schofield, L., Rana, N., Kirk, M., Mitchell, G.F., Poppas, A., Zehender, M., Koren, G., Mechanisms of cardiac arrhythmias and sudden death in transgenic rabbits with long QT syndrome. J. Clin. Investig., 2008, 10.1172/JCI33578.
20. Carlsson, L., The anaesthetised methoxamine-sensitised rabbit model of torsades de pointes. Pharmacol. Ther. 119 (2008), 160–167, 10.1016/j.pharmthera.2008.04.004.
21. Carlsson, L., Andersson, B., Linhardt, G., Löfberg, L., Assessment of the ion channel-blocking profile of the novel combined ion channel blocker AZD1305 and its proarrhythmic potential versus dofetilide in the methoxamine-sensitized rabbit in vivo. J. Cardiovasc. Pharmacol. 54 (2009), 82–89, 10.1097/FJC.0b013e3181ac62c9.
22. Casimiro, M.C., Knollmann, B.C., Ebert, S.N., Vary, J.C., Greene, A.E., Franz, M.R., Grinberg, A., Huang, S.P., Pfeifer, K., Targeted disruption of the Kcnq1 gene produces a mouse model of Jervell and Lange-Nielsen Syndrome. Proc. Natl. Acad. Sci. U.S.A. 98 (2001), 2526–2531, 10.1073/pnas.041398998.
23. Castro-Torres, Y., Carmona-Puerta, R., Katholi, R.E., Ventricular repolarization markers for predicting malignant arrhythmias in clinical practice. World J. Clin. Cases 3 (2015), 705–720, 10.12998/wjcc.v3.i8.705.
24. Chevalier, P., Bellocq, C., Millat, G., Piqueras, E., Potet, F., Schott, J.-J., Baró, I., Lemarec, H., Barhanin, J., Rousson, R., Rodriguez-Lafrasse, C., Torsades de pointes complicating atrioventricular block: evidence for a genetic predisposition. Heart Rhythm. 4 (2007), 170–174, 10.1016/j.hrthm.2006.10.004.
25. Choi, B.-R., Burton, F., Salama, G., Cytosolic Ca2+ triggers early afterdepolarizations and Torsade de pointes in rabbit hearts with type 2 long QT syndrome. J. Physiol. 543 (2002), 615–631, 10.1113/jphysiol.2002.024570.
26. Chouabe, C., Neyroud, N., Guicheney, P., Lazdunski, M., Romey, G., Barhanin, J., Properties of KvLQT1 K+ channel mutations in Romano-Ward and Jervell and Lange-Nielsen inherited cardiac arrhythmias. EMBO J. 16 (1997), 5472–5479, 10.1093/emboj/16.17.5472.
27. Demolombe, S., Lande, G., Charpentier, F., van Roon, M.A., van den Hoff, M.J., Toumaniantz, G., Baro, I., Guihard, G., Le Berre, N., Corbier, A., de Bakker, J., Opthof, T., Wilde, A., Moorman, A.F., Escande, D., Transgenic mice overexpressing human KvLQT1 dominant-negative isoform. Part I: phenotypic characterisation. Cardiovasc. Res. 50 (2001), 314–327.
28. Derangeon, M., Montnach, J., Baró, I., Charpentier, F., Mouse models of SCN5A-related cardiac arrhythmias. Front. Physiol., 3, 2012, 210, 10.3389/fphys.2012.00210.
29. Diness, T.G., Yeh, Y.-H., Qi, X.Y., Chartier, D., Tsuji, Y., Hansen, R.S., Olesen, S.-P., Grunnet, M., Nattel, S., Antiarrhythmic properties of a rapid delayed-rectifier current activator in rabbit models of acquired long QT syndrome. Cardiovasc. Res. 79 (2008), 61–69, 10.1093/cvr/cvn075.
30. Dressler, F., Bodi, I., Schneider, J.R.E., Behrends, J.C., Seemann, G., Odening, K.E., Regional electromechanical heterogeneity in the rabbit wild-type and Long-QT syndrome heart. Circ. Suppl., 2015, A13021.
31. Eddy, C.-A., MacCormick, J.M., Chung, S.-K., Crawford, J.R., Love, D.R., Rees, M.I., Skinner, J.R., Shelling, A.N., Identification of large gene deletions and duplications in KCNQ1 and KCNH2 in patients with long QT syndrome. Heart Rhythm. 5 (2008), 1275–1281, 10.1016/j.hrthm.2008.05.033.
32. Fabritz, L., Kirchhof, P., Franz, M.R., Nuyens, D., Rossenbacker, T., Ottenhof, A., Haverkamp, W., Breithardt, G., Carmeliet, E., Carmeliet, P., Effect of pacing and mexiletine on dispersion of repolarisation and arrhythmias in DeltaKPQ SCN5A (long QT3) mice. Cardiovasc. Res. 57 (2003), 1085–1093.
33. Furukawa, T., Kurokawa, J., Non-genomic regulation of cardiac ion channels by sex hormones. Cardiovasc. Hematol. Disord. Drug Targets 8 (2008), 245–251.
34. Gorgels, A.P., Fadley, Al, F., Zaman, L., Kantoch, M.J., Halees, Al, Z., The long QT syndrome with impaired atrioventricular conduction: a malignant variant in infants. J. Cardiovasc. Electrophysiol. 9 (1998), 1225–1232.
35. Gravelin, L., Ziv, O., Hartmann, M., Patel, D., Schofield, L., Transgenic LQT1 animal model reveals shifting foci of EADs as mechanism for polymorphic VT. Heart Rhythm. 9 (2012), P03–P104.
36. Guo, W., Li, H., London, B., Nerbonne, J.M., Functional consequences of elimination of i(to,f) and i(to,s): early afterdepolarizations, atrioventricular block, and ventricular arrhythmias in mice lacking Kv1.4 and expressing a dominant-negative Kv4 alpha subunit. Circ. Res. 87 (2000), 73–79.
37. Guo, X., Gao, X., Wang, Y., Peng, L., Zhu, Y., Wang, S., IKs protects from ventricular arrhythmia during cardiac ischemia and reperfusion in rabbits by preserving the repolarization reserve. PLoS One, 7, 2012, e31545, 10.1371/journal.pone.0031545.
38. Haugaa, K.H., Amlie, J.P., Berge, K.E., Leren, T.P., Smiseth, O.A., Edvardsen, T., Transmural differences in myocardial contraction in Long-QT syndrome: mechanical consequences of ion channel dysfunction. Circulation 122 (2010), 1355–1363, 10.1161/CIRCULATIONAHA.110.960377.
39. Haugaa, K.H., Edvardsen, T., Leren, T.P., Gran, J.M., Smiseth, O.A., Amlie, J.P., Left ventricular mechanical dispersion by tissue Doppler imaging: a novel approach for identifying high-risk individuals with long QT syndrome. Eur. Heart J. 30 (2008), 330–337, 10.1093/eurheartj/ehn466.
40. Hayashi, H., Shiferaw, Y., Sato, D., Nihei, M., Lin, S.-F., Chen, P.-S., Garfinkel, A., Weiss, J.N., Qu, Z., Dynamic origin of spatially discordant alternans in cardiac tissue. Biophys. J. 92 (2007), 448–460, 10.1529/biophysj.106.091009.
41. Inaba, H., Hayami, N., Ajiki, K., Kunishima, T., Watanabe, H., Tsutsui, K., Yamagishi, N., Yamagishi, S., Sugiura, A., Mikamo, T., Murakawa, Y., Deep anesthesia suppresses ventricular tachyarrhythmias in rabbit model of the acquired long QT syndrome. Circ. J. 75 (2011), 89–93.
42. Jacobson, I., Carlsson, L., Duker, G., Beat-by-beat QT interval variability, but not QT prolongation per se, predicts drug-induced torsades de pointes in the anaesthetised methoxamine-sensitized rabbit. J. Pharmacol. Toxicol. Methods 63 (2011), 40–46, 10.1016/j.vascn.2010.04.010.
43. James, J., Sanbe, A., Yager, K., Martin, L., Klevitsky, R., Robbins, J., Genetic manipulation of the rabbit heart via transgenesis. Circulation 101 (2000), 1715–1721.
44. January, C.T., Riddle, J.M., Early afterdepolarizations: mechanism of induction and block. A role for L-type Ca2+ current. Circ. Res. 64 (1989), 977–990.
45. Jindal, H.K., Merchant, E., Balschi, J.A., Zhangand, Y., Koren, G., Proteomic analyses of transgenic LQT1 and LQT2 rabbit hearts elucidate an increase in expression and activity of energy producing enzymes. J. Proteom. 75 (2012), 5254–5265, 10.1016/j.jprot.2012.06.034.
46. Jung, B., Odening, K.E., Armellina, E.D., ll, D.F., Menza, M., Markl, M., Schneider, J.R.E., A quantitative comparison of regional myocardial motion in mice, rabbits and humans using in-vivo phase contrast CMR. J. Cardiovasc. Magn. Reson., 14, 2012, 10.1186/1532-429X-14-87 1–1.
47. Kannankeril, P., Roden, D.M., Darbar, D., Drug-induced long QT syndrome. Pharmacol. Rev. 62 (2010), 760–781, 10.1124/pr.110.003723.
48. Kannankeril, P.J., Roden, D.M., Norris, K.J., Whalen, S.P., George, A.L., Murray, K.T., Genetic susceptibility to acquired long QT syndrome: pharmacologic challenge in first-degree relatives. Heart Rhythm. 2 (2005), 134–140, 10.1016/j.hrthm.2004.10.039.
49. Kanters, J.K., Haarmark, C., Vedel-Larsen, E., Andersen, M.P., Graff, C., Struijk, J.J., Thomsen, P.E.B., Christiansen, M., Jensen, H.K., Toft, E., T(peak)T(end) interval in long QT syndrome. J. Electrocardiol. 41 (2008), 603–608, 10.1016/j.jelectrocard.2008.07.024.
50. Keating, M.T., Sanguinetti, M.C., Molecular and cellular mechanisms of cardiac arrhythmias. Cell 104 (2001), 569–580.
51. Khobragade, S.B., Gupta, P., Gurav, P., Chaudhari, G., Gatne, M.M., Shingatgeri, V.M., Assessment of proarrhythmic activity of chloroquine in in vivo and ex vivo rabbit models. J. Pharmacol. Pharmacother. 4 (2013), 116–124, 10.4103/0976-500X.110892.
52. Kim, T.Y., Kunitomo, Y., Pfeiffer, Z., Patel, D., Hwang, J., Harrison, K., Patel, B., Jeng, P., Ziv, O., Lu, Y., Peng, X., Qu, Z., Koren, G., Choi, B.-R., Complex excitation dynamics underlie polymorphic ventricular tachycardia in a transgenic rabbit model of long QT syndrome type 1. Heart Rhythm. 12 (2015), 220–228, 10.1016/j.hrthm.2014.10.003.
53. Kodirov, S.A., Brunner, M., Busconi, L., Koren, G., Long-term restitution of 4-aminopyridine-sensitive currents in Kv1DN ventricular myocytes using adeno-associated virus-mediated delivery of Kv1.5. FEBS Lett. 550 (2003), 74–78.
54. Kodirov, S.A., Brunner, M., Nerbonne, J.M., Buckett, P., Mitchell, G.F., Koren, G., Attenuation of I(K,slow1) and I(K,slow2) in Kv1/Kv2DN mice prolongs APD and QT intervals but does not suppress spontaneous or inducible arrhythmias. Am. J. Physiol. Heart Circ. Physiol. 286 (2004), H368–H374, 10.1152/ajpheart.00303.2003.
55. Koopmann, T.T., Alders, M., Jongbloed, R.J., Guerrero, S., Mannens, M.M.A.M., Wilde, A.A.M., Bezzina, C.R., Long QT syndrome caused by a large duplication in the KCNH2 (HERG) gene undetectable by current polymerase chain reaction-based exon-scanning methodologies. Heart Rhythm. 3 (2006), 52–55, 10.1016/j.hrthm.2005.10.014.
56. 2+ handling proteins account for dispersion of electro-mechanical dysfunction in transgenic LQT1 rabbits. Heart Rhythm., 13, 2016 Supplement, S277 (PO03-68).
57. Koren, G., Electrical remodeling and arrhythmias in long-QT syndrome: lessons from genetic models in mice. Ann. Med. 36:Suppl. 1 (2004), 22–27.
58. Kurokawa, J., Tamagawa, M., Harada, N., Honda, S.-I., Bai, C.-X., Nakaya, H., Furukawa, T., Acute effects of oestrogen on the guinea pig and human IKr channels and drug-induced prolongation of cardiac repolarization. J. Physiol. 586 (2008), 2961–2973, 10.1113/jphysiol.2007.150367.
59. Lang, C.N., Menza, M., Jochem, S., Franke, G., Feliz, S.P., Brunner, M., Koren, G., Zehender, M., Bugger, H., Jung, B.A., Foell, D., Bode, C., Odening, K.E., Electro-mechanical dysfunction in long QT syndrome: role for arrhythmogenic risk prediction and modulation by sex and sex hormones. Prog. Biophys. Mol. Biol., 2016, 10.1016/j.pbiomolbio.2015.12.010.
60. Lau, E., Kossidas, K., Kim, T.Y., Kunitomo, Y., Ziv, O., Zhen, S., Taylor, C., Schofield, L., Yammine, J., Liu, G., Peng, X., Qu, Z., Koren, G., Choi, B.-R., Spatially discordant alternans and arrhythmias in tachypacing-induced cardiac myopathy in transgenic LQT1 rabbits: the importance of IKs and Ca2+ cycling. PLoS One, 10, 2015, e0122754, 10.1371/journal.pone.0122754.
61. Lee, M.P., Ravenel, J.D., Hu, R.J., Lustig, L.R., Tomaselli, G., Berger, R.D., Brandenburg, S.A., Litzi, T.J., Bunton, T.E., Limb, C., Francis, H., Gorelikow, M., Gu, H., Washington, K., Argani, P., Goldenring, J.R., Coffey, R.J., Feinberg, A.P., Targeted disruption of the Kvlqt1 gene causes deafness and gastric hyperplasia in mice. J. Clin. Investig. 106 (2000), 1447–1455, 10.1172/JCI10897.
62. Leoni, A.-L., Gavillet, B., Rougier, J.-S., Marionneau, C., Probst, V., Le Scouarnec, S., Schott, J.-J., Demolombe, S., Bruneval, P., Huang, C.L.H., Colledge, W.H., Grace, A.A., Le Marec, H., Wilde, A.A., Mohler, P.J., Escande, D., Abriel, H., Charpentier, F., Variable Na(v)1.5 protein expression from the wild-type allele correlates with the penetrance of cardiac conduction disease in the Scn5a(+/-) mouse model. PLoS One, 5, 2010, e9298, 10.1371/journal.pone.0009298.
63. Leren, I.S., Hasselberg, N.E., Saberniak, J., Håland, T.F., Kongsgård, E., Smiseth, O.A., Edvardsen, T., Haugaa, K.H., Cardiac mechanical alterations and genotype dpecific differences in subjects with long QT syndrome. JACC Cardiovasc. Imaging 8 (2015), 501–510, 10.1016/j.jcmg.2014.12.023.
64. Li, H., Guo, W., Yamada, K.A., Nerbonne, J.M., Selective elimination of I(K,slow1) in mouse ventricular myocytes expressing a dominant negative Kv1.5alpha subunit. Am. J. Physiol. Heart Circ. Physiol. 286 (2004), H319–H328, 10.1152/ajpheart.00665.2003.
65. Li, J., Maguy, A., Duverger, J.E., Vigneault, P., Comtois, P., Shi, Y., Tardif, J.-C., Thomas, D., Nattel, S., Induced KCNQ1 autoimmunity accelerates cardiac repolarization in rabbits: potential significance in arrhythmogenesis and antiarrhythmic therapy. Heart Rhythm. 11 (2014), 2092–2100, 10.1016/j.hrthm.2014.07.040.
66. Liu, G.X., Choi, B.-R., Ziv, O., Li, W., de Lange, E., Qu, Z., Koren, G., Differential conditions for early after-depolarizations and triggered activity in cardiomyocytes derived from transgenic LQT1 and LQT2 rabbits. J. Physiol. 590 (2012), 1171–1180, 10.1113/jphysiol.2011.218164.
67. Liu, X.-K., Katchman, A., Whitfield, B.H., Wan, G., Janowski, E.M., Woosley, R.L., Ebert, S.N., In vivo androgen treatment shortens the QT interval and increases the densities of inward and delayed rectifier potassium currents in orchiectomized male rabbits. Cardiovasc. Res. 57 (2003), 28–36.
68. Liu, X.K., Katchman, A., Drici, M.D., Ebert, S.N., Ducic, I., Morad, M., Woosley, R.L., Gender difference in the cycle length-dependent QT and potassium currents in rabbits. J. Pharmacol. Exp. Ther. 285 (1998), 672–679.
69. Locati, E.H., Zareba, W., Moss, A.J., Schwartz, P.J., Vincent, G.M., Lehmann, M.H., Towbin, J.A., Priori, S.G., Napolitano, C., Robinson, J.L., Andrews, M., Timothy, K., Hall, W.J., Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry. Circulation 97 (1998), 2237–2244.
70. London, B., Jeron, A., Zhou, J., Buckett, P., Han, X., Mitchell, G.F., Koren, G., Long QT and ventricular arrhythmias in transgenic mice expressing the N terminus and first transmembrane segment of a voltage-gated potassium channel. Proc. Natl. Acad. Sci. U. S. A. 95 (1998), 2926–2931.
71. Lubinski, A., Lewicka-Nowak, E., Kempa, M., Baczynska, A.M., Romanowska, I., Swiatecka, G., New insight into repolarization abnormalities in patients with congenital long QT syndrome: the increased transmural dispersion of repolarization. Pacing Clin. Electrophysiol. 21 (1998), 172–175.
72. Major, P., Baczkó, I., Hipiri, L., Odening, K.E., Juhasz, V., Kohajda, Z., Horvath, A., Seprenyi, G., Kovacs, M., Ordog, B., Doleschall, Z., Nattel, S., Varró, A., Bosze, Z., A novel transgenic rabbit model with reduced repolarization reserve: long QT syndrome caused by a dominant-negative mutation of KCNE1 gene. 2016 Apr 14 Br. J. Pharmacol., 2016, 10.1111/bph.13500 ([Epub ahead of print]).
73. Maruyama, M., Lin, S.-F., Xie, Y., Chua, S.-K., Joung, B., Han, S., Shinohara, T., Shen, M.J., Qu, Z., Weiss, J.N., Chen, P.-S., Genesis of phase 3 early afterdepolarizations and triggered activity in acquired long-QT syndrome. Circ. Arrhythm. Electrophysiol. 4 (2011), 103–111, 10.1161/CIRCEP.110.959064.
74. Morita, H., Wu, J., Zipes, D.P., The QT syndromes: long and short. Lancet 372 (2008), 750–763, 10.1016/S0140-6736(08)61307-0.
75. Moshal, K.S., Zhang, Z., Roder, K., Kim, T.Y., Cooper, L., Patedakis Litvinov, B., Lu, Y., Reddy, V., Terentyev, D., Choi, B.-R., Koren, G., Progesterone modulates SERCA2a expression and function in rabbit cardiomyocytes. Am. J. Physiol. Cell Physiol. 307 (2014), C1050–C1057, 10.1152/ajpcell.00127.2014.
76. Moss, A.J., Increased risk of arrhythmic events in Long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel. Circulation 105 (2002), 794–799, 10.1161/hc0702.105124.
77. Moss, A.J., Shimizu, W., Wilde, A.A.M., Towbin, J.A., Zareba, W., Robinson, J.L., Qi, M., Vincent, G.M., Ackerman, M.J., Kaufman, E.S., Hofman, N., Seth, R., Kamakura, S., Miyamoto, Y., Goldenberg, I., Andrews, M.L., McNitt, S., Clinical aspects of type-1 Long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene. Circulation 115 (2007), 2481–2489, 10.1161/CIRCULATIONAHA.106.665406.
78. Mow, T., Frederiksen, K., Thomsen, M.B., Assessment of anti-arrhythmic activity of antipsychotic drugs in an animal model: influence of non-cardiac α₁-adrenergic receptors. Eur. J. Pharmacol. 748 (2015), 10–17, 10.1016/j.ejphar.2014.12.012.
79. Nador, F., Beria, G., De Ferrari, G.M., Stramba-Badiale, M., Locati, E.H., Lotto, A., Schwartz, P.J., Unsuspected echocardiographic abnormality in the long QT syndrome. Diagnostic, prognostic, and pathogenetic implications. Circulation 84 (1991), 1530–1542.
80. Nagaoka, I., Shimizu, W., Itoh, H., Yamamoto, S., Sakaguchi, T., Oka, Y., Tsuji, K., Ashihara, T., Ito, M., Yoshida, H., Ohno, S., Makiyama, T., Miyamoto, Y., Noda, T., Kamakura, S., Akao, M., Horie, M., Mutation site dependent variability of cardiac events in Japanese LQT2 form of congenital long-QT syndrome. Circ. J. 72 (2008), 694–699.
81. Nakayama, K., Yamanari, H., Otsuka, F., Fukushima, K., Saito, H., Fujimoto, Y., Emori, T., Matsubara, H., Uchida, S., Ohe, T., Dispersion of regional wall motion abnormality in patients with long QT syndrome. Heart 80 (1998), 245–250.
82. Nalos, L., Varkevisser, R., Jonsson, M.K.B., Houtman, M.J.C., Beekman, J.D., van der Nagel, R., Thomsen, M.B., Duker, G., Sartipy, P., de Boer, T.P., Peschar, M., Rook, M.B., van Veen, T.A.B., van der Heyden, M.A.G., Vos, M.A., Comparison of the IKr blockers moxifloxacin, dofetilide and E-4031 in five screening models of pro-arrhythmia reveals lack of specificity of isolated cardiomyocytes. Br. J. Pharmacol. 165 (2012), 467–478, 10.1111/j.1476-5381.2011.01558.x.
83. Napolitano, C., Novelli, V., Francis, M.D., Priori, S.G., Genetic modulators of the phenotype in the long QT syndrome: state of the art and clinical impact. Curr. Opin. Genet. Dev. 33 (2015), 17–24, 10.1016/j.gde.2015.06.009.
84. Napolitano, C., Priori, S.G., Schwartz, P.J., Bloise, R., Ronchetti, E., Nastoli, J., Bottelli, G., Cerrone, M., Leonardi, S., Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice. J. Am. Med. Assoc. 294 (2005), 2975–2980, 10.1001/jama.294.23.2975.
85. Nemec, J., Ackerman, M.J., Tester, D.J., Hejlik, J., Shen, W.-K., Catecholamine-provoked microvoltage T wave alternans in genotyped long QT syndrome. Pacing Clin. Electrophysiol. 26 (2003), 1660–1667.
86. Nerbonne, J.M., Molecular basis of functional voltage-gated K+ channel diversity in the mammalian myocardium. J. Physiol. 525:Pt 2 (2000), 285–298.
87. Nerbonne, J.M., Nichols, C.G., Schwarz, T.L., Escande, D., Genetic manipulation of cardiac K(+) channel function in mice: what have we learned, and where do we go from here?. Circulation Res. 89 (2001), 944–956.
88. Noda, T., Shimizu, W., Satomi, K., Suyama, K., Kurita, T., Aihara, N., Kamakura, S., Classification and mechanism of initiation in patients with congenital long QT syndrome. Eur. Heart J. 25 (2004), 2149–2154, 10.1016/j.ehj.2004.08.020.
89. Nuyens, D., Stengl, M., Dugarmaa, S., Rossenbacker, T., Compernolle, V., Rudy, Y., Smits, J.F., Flameng, W., Clancy, C.E., Moons, L., Vos, M.A., Dewerchin, M., Benndorf, K., Collen, D., Carmeliet, E., Carmeliet, P., Abrupt rate accelerations or premature beats cause life-threatening arrhythmias in mice with long-QT3 syndrome. Nat. Med. 7 (2001), 1021–1027, 10.1038/nm0901-1021.
90. Odening, K.E., Choi, B.-R., Liu, G.X., Hartmann, K., Ziv, O., Chaves, L., Schofield, L., Centracchio, J., Zehender, M., Peng, X., Brunner, M., Koren, G., Estradiol promotes sudden cardiac death in transgenic long QT type 2 rabbits while progesterone is protective. Heart Rhythm. 9 (2012), 823–832, 10.1016/j.hrthm.2012.01.009.
91. Odening, K.E., Hyder, O., Chaves, L., Schofield, L., Brunner, M., Kirk, M., Zehender, M., Peng, X., Koren, G., Pharmacogenomics of anesthetic drugs in transgenic LQT1 and LQT2 rabbits reveal genotype-specific differential effects on cardiac repolarization. AJP Heart Circ. Physiol. 295 (2008), H2264–H2272, 10.1152/ajpheart.00680.2008.
92. Odening, K.E., Jung, B.A., Lang, C.N., Cabrera Lozoya, R., Ziupa, D., Menza, M., Relan, J., Franke, G., Perez Feliz, S., Koren, G., Zehender, M., Bode, C., Brunner, M., Sermesant, M., Föll, D., Spatial correlation of action potential duration and diastolic dysfunction in transgenic and drug-induced LQT2 rabbits. Heart Rhythm. 10 (2013), 1533–1541, 10.1016/j.hrthm.2013.07.038.
93. Odening, K.E., Kirk, M., Brunner, M., Ziv, O., Lorvidhaya, P., Liu, G.X., Schofield, L., Chaves, L., Peng, X., Zehender, M., Choi, B.R., Koren, G., Electrophysiological studies of transgenic long QT type 1 and type 2 rabbits reveal genotype-specific differences in ventricular refractoriness and His conduction. AJP Heart Circ. Physiol. 299 (2010), H643–H655, 10.1152/ajpheart.00074.2010.
94. Odening, K.E., Koren, G., How do sex hormones modify arrhythmogenesis in long QT syndrome? Sex hormone effects on arrhythmogenic substrate and triggered activity. Heart Rhythm. 11 (2014), 2107–2115, 10.1016/j.hrthm.2014.06.023.
95. Organ-Darling, L.E., Vernon, A.N., Giovanniello, J.R., Lu, Y., Moshal, K., Roder, K., Li, W., Koren, G., Interactions between hERG and KCNQ1 α-subunits are mediated by their COOH termini and modulated by cAMP. AJP Heart Circ. Physiol. 304 (2013), H589–H599, 10.1152/ajpheart.00385.2012.
96. Parikh, A., Mantravadi, R., Kozhevnikov, D., Roche, M.A., Ye, Y., Owen, L.J., Puglisi, J.L., Abramson, J.J., Salama, G., Ranolazine stabilizes cardiac ryanodine receptors: a novel mechanism for the suppression of early afterdepolarization and torsades de pointes in long QT type 2. Heart Rhythm. 9 (2012), 953–960, 10.1016/j.hrthm.2012.01.010.
97. Pezhouman, A., Singh, N., Song, Z., Nivala, M., Eskandari, A., Cao, H., Bapat, A., Ko, C.Y., Nguyen, T.P., Qu, Z., Karagueuzian, H.S., Weiss, J.N., Molecular basis of hypokalemia-induced ventricular fibrillation. Circulation 132 (2015), 1528–1537, 10.1161/CIRCULATIONAHA.115.016217.
98. Priori, S., The long QT syndrome. Europace 3 (2001), 16–27, 10.1053/eupc.2000.0141.
99. Priori, S.G., Blomstrφm-Lundqvist, A.M., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., Perry, M.E., Fitzsimons, D., Hatala, R., Hindricks, G., Kirchhof, P., Kjeldsen, K., Kuck, K.-H., Hernandez-Madrid, A., Nikolaou, N., Norekval, T.M., Spaulding, C., Van Veldhuisen, D.J., 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur. Heart J. 36 (2015), 2793–2867, 10.1093/eurheartj/ehv316.
100. Priori, S.G., Chen, S.R.W., Inherited dysfunction of sarcoplasmic reticulum Ca2+ handling and arrhythmogenesis. Circ. Res. 108 (2011), 871–883, 10.1161/CIRCRESAHA.110.226845.
101. Priori, S.G., Napolitano, C., Diehl, L., Schwartz, P.J., Dispersion of the QT interval. A marker of therapeutic efficacy in the idiopathic long QT syndrome. Circulation 89 (1994), 1681–1689.
102. Pruvot, E., De Torrente, A., De Ferrari, G.M., Schwartz, P.J., Goy, J.J., Two-to-one AV block associated with the congenital long QT syndrome. J. Cardiovasc. Electrophysiol. 10 (1999), 108–113.
103. Raviρa, T., Raviρa, P., Gutierrez, J., Acquired long QT syndrome: risperidone-facilitated triggered activity and Torsades de Pointes during complete AV block. I. Int. J. Cardiol. 116 (2007), 416–420, 10.1016/j.ijcard.2006.04.084.
104. Ren, X.-Q., Liu, G.X., Organ-Darling, L.E., Zheng, R., Roder, K., Jindal, H.K., Centracchio, J., McDonald, T.V., Koren, G., Pore mutants of HERG and KvLQT1 downregulate the reciprocal currents in stable cell lines. AJP Heart Circ. Physiol. 299 (2010), H1525–H1534, 10.1152/ajpheart.00479.2009.
105. Roden, D.M., Clinical practice. Long-QT syndrome. N. Engl. J. Med. 358 (2008), 169–176, 10.1056/NEJMcp0706513.
106. Roden, D.M., Long QT syndrome: reduced repolarization reserve and the genetic link. J. Intern. Med. 259 (2006), 59–69, 10.1111/j.1365-2796.2005.01589.x.
107. Rosenbaum, M.B., Acunzo, R.S., Pseudo 2:1 atrioventricular block and T wave alternans in the long QT syndromes. J. Am. Coll. Cardiol. 18 (1991), 1363–1366.
108. Sakaguchi, T., Shimizu, W., Itoh, H., Noda, T., Miyamoto, Y., Nagaoka, I., Oka, Y., Ashihara, T., Ito, M., Tsuji, K., Ohno, S., Makiyama, T., Kamakura, S., Horie, M., Age- and genotype-specific triggers for life-threatening arrhythmia in the genotyped long QT syndrome. J. Cardiovasc. Electrophysiol. 19 (2008), 794–799, 10.1111/j.1540-8167.2008.01138.x.
109. Salama, G., London, B., Mouse models of long QT syndrome. J. Physiol. 578 (2007), 43–53, 10.1113/jphysiol.2006.118745.
110. Salata, J.J., Jurkiewicz, N.K., Jow, B., Folander, K., Guinosso, P.J., Raynor, B., Swanson, R., Fermini, B., IK of rabbit ventricle is composed of two currents: evidence for IKs. Am. J. Physiol. 271 (1996), H2477–H2489.
111. Sanguinetti, M.C., Curran, M.E., Spector, P.S., Keating, M.T., Spectrum of HERG K+-channel dysfunction in an inherited cardiac arrhythmia. Proc. Natl. Acad. Sci. U. S. A. 93 (1996), 2208–2212.
112. Sanguinetti, M.C., Jiang, C., Curran, M.E., Keating, M.T., A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell 81 (1995), 299–307.
113. Sauer, A.J., Moss, A.J., McNitt, S., Peterson, D.R., Zareba, W., Robinson, J.L., Qi, M., Goldenberg, I., Hobbs, J.B., Ackerman, M.J., Benhorin, J., Hall, W.J., Kaufman, E.S., Locati, E.H., Napolitano, C., Priori, S.G., Schwartz, P.J., Towbin, J.A., Vincent, G.M., Zhang, L., Long QT Syndrome Adults 49 (2007), 329–337, 10.1016/j.jacc.2006.08.057.
114. Schmeling, W.T., Warltier, D.C., McDonald, D.J., Madsen, K.E., Atlee, J.L., Kampine, J.P., Prolongation of the QT interval by enflurane, isoflurane, and halothane in humans. Anesth. Analg. 72 (1991), 137–144.
115. Schwartz, P.J., Segantini, A., Cardiac innervation, neonatal electrocardiography, and SIDS. A key for a novel preventive strategy?. Ann. N. Y. Acad. Sci. 533 (1988), 210–220.
116. Schwartz, P.J., Stramba-Badiale, M., Crotti, L., Pedrazzini, M., Besana, A., Bosi, G., Gabbarini, F., Goulene, K., Insolia, R., Mannarino, S., Mosca, F., Nespoli, L., Rimini, A., Rosati, E., Salice, P., Spazzolini, C., Prevalence of the congenital long-QT syndrome. Circulation 120 (2009), 1761–1767, 10.1161/CIRCULATIONAHA.109.863209.
117. Shimizu, W., Moss, A.J., Wilde, A.A.M., Towbin, J.A., Ackerman, M.J., January, C.T., Tester, D.J., Zareba, W., Robinson, J.L., Qi, M., Vincent, G.M., Kaufman, E.S., Hofman, N., Noda, T., Kamakura, S., Miyamoto, Y., Shah, S., Amin, V., Goldenberg, I., Andrews, M.L., McNitt, S., Genotype-phenotype aspects of type 2 long QT syndrome. J. Am. Coll. Cardiol. 54 (2009), 2052–2062, 10.1016/j.jacc.2009.08.028.
118. Splawski, I., Shen, J., Timothy, K.W., Lehmann, M.H., Priori, S., Robinson, J.L., Moss, A.J., Schwartz, P.J., Towbin, J.A., Vincent, G.M., Keating, M.T., Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation 102 (2000), 1178–1185.
119. Stuyvers, B.D., Miura, M., Keurs, ter, H.E., Ca(2+)-dependence of passive properties of cardiac sarcomeres. Adv. Exp. Med. Biol. 481 (2000), 353–366 discussion 367–70.
120. Tan, H.L., Bardai, A., Shimizu, W., Moss, A.J., Schulze-Bahr, E., Noda, T., Wilde, A.A.M., Genotype-specific onset of arrhythmias in congenital Long-QT syndrome: possible therapy implications. Circulation 114 (2006), 2096–2103, 10.1161/CIRCULATIONAHA.106.642694.
121. Terentyev, D., Rees, C.M., Li, W., Cooper, L.L., Jindal, H.K., Peng, X., Lu, Y., Terentyeva, R., Odening, K.E., Daley, J., Bist, K., Choi, B.-R., Karma, A., Koren, G., Hyperphosphorylation of RyRs underlies triggered activity in transgenic rabbit model of LQT2 syndrome. Circ. Res. 115 (2014), 919–928, 10.1161/CIRCRESAHA.115.305146.
122. Tester, D.J., Ackerman, M.J., Genetics of long QT syndrome. Methodist Debakey Cardiovasc. J. 10 (2014), 29–33.
123. Tester, D.J., Ackerman, M.J., Genetic testing for potentially lethal, highly treatable inherited cardiomyopathies/channelopathies in clinical practice. Circulation 123 (2011), 1021–1037, 10.1161/CIRCULATIONAHA.109.914838.
124. Tester, D.J., Benton, A.J., Train, L., Deal, B., Baudhuin, L.M., Ackerman, M.J., Prevalence and spectrum of large deletions or duplications in the major long QT syndrome-susceptibility genes and implications for long QT syndrome genetic testing. Am. J. Cardiol. 106 (2010), 1124–1128, 10.1016/j.amjcard.2010.06.022.
125. Tester, D.J., Will, M.L., Haglund, C.M., Ackerman, M.J., Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing. Heart Rhythm. 2 (2005), 507–517, 10.1016/j.hrthm.2005.01.020.
126. Tsutsui, K., Hayami, N., Kunishima, T., Sugiura, A., Mikamo, T., Kanamori, K., Yamagishi, N., Yamagishi, S., Watanabe, H., Ajiki, K., Murakawa, Y., Dexmedetomidine and clonidine inhibit ventricular tachyarrhythmias in a rabbit model of acquired long QT syndrome. Circ. J. 76 (2012), 2343–2347.
127. Varkevisser, R., Vos, M.A., Beekman, J.D., Tieland, R.G., Van Der Heyden, M.A., AV-block and conduction slowing prevail over TdP arrhythmias in the methoxamine-sensitized pro-arrhythmic rabbit model. J. Cardiovasc. Electrophysiol. 26 (2015), 82–89, 10.1111/jce.12533.
128. Varkevisser, R., Wijers, S.C., van der Heyden, M.A.G., Beekman, J.D.M., Meine, M., Vos, M.A., Beat-to-beat variability of repolarization as a new biomarker for proarrhythmia in vivo. Heart Rhythm. 9 (2012), 1718–1726, 10.1016/j.hrthm.2012.05.016.
129. Varro, A., Baczkσ, I., Cardiac ventricular repolarization reserve: a principle for understanding drug-related proarrhythmic risk. Br. J. Pharmacol. 164 (2011), 14–36, 10.1111/j.1476-5381.2011.01367.x.
130. Vijayakumar, R., Silva, J.N.A., Desouza, K.A., Abraham, R.L., Strom, M., Sacher, F., Van Hare, G.F., Haοssaguerre, M., Roden, D.M., Rudy, Y., Electrophysiologic substrate in congenital Long QT syndrome: noninvasive mapping with electrocardiographic imaging (ECGI). Circulation 130 (2014), 1936–1943, 10.1161/CIRCULATIONAHA.114.011359.
131. Wang, Q., Shen, J., Li, Z., Timothy, K., Vincent, G.M., Priori, S.G., Schwartz, P.J., Keating, M.T., Cardiac sodium channel mutations in patients with long QT syndrome, an inherited cardiac arrhythmia. Hum. Mol. Genet. 4 (1995), 1603–1607.
132. Wang, W.-L., Zhang, S.-S., Deng, J., Zhao, J.-Y., Zhao, C.-Q., Lin, L., Zhang, C.-T., Lv, J.-G., KN-93, A CaMKII inhibitor, suppresses ventricular arrhythmia induced by LQT2 without decreasing TDR. J. Huazhong Univ. Sci. Technol. Med. Sci. 33 (2013), 636–639, 10.1007/s11596-013-1172-1.
133. Wilson, L.D., Rosenbaum, D.S., Mechanisms of arrythmogenic cardiac alternans. Europace, 9(Suppl. 6), 2007, 10.1093/europace/eum210 vi77–82.
134. Xu, H., Barry, D.M., Li, H., Brunet, S., Guo, W., Nerbonne, J.M., Attenuation of the slow component of delayed rectification, action potential prolongation, and triggered activity in mice expressing a dominant-negative Kv2 alpha subunit. Circ. Res. 85 (1999), 623–633.
135. Yamamoto, A., Yamamoto, G., Ohfu, M., Hamamoto, K., Yasumoto, S., Hirose, S., Criteria for differential diagnosis of epilepsy and long QT syndrome presenting with seizures and EEG abnormalities. No To Hattatsu 41 (2009), 442–446.
136. Yang, P., Allelic variants in Long-QT disease genes in patients with drug-associated torsades de pointes. Circulation 105 (2002), 1943–1948, 10.1161/01.CIR.0000014448.19052.4C.
137. Zareba, W., Moss, A.J., le Cessie, S., Hall, W.J., T wave alternans in idiopathic long QT syndrome. J. Am.Coll. Cardiol. 23 (1994), 1541–1546.
138. Zimik, S., Vandersickel, N., Nayak, A.R., Panfilov, A.V., Pandit, R., A Comparative study of early afterdepolarization-mediated fibrillation in two mathematical models for human ventricular cells. PLoS One, 10, 2015, e0130632, 10.1371/journal.pone.0130632.
139. Ziupa, D., Beck, J., Franke, G., Perez Feliz, S., Hartmann, M., Koren, G., Zehender, M., Bode, C., Brunner, M., Odening, K.E., Pronounced effects of HERG-blockers E-4031 and erythromycin on APD, spatial APD dispersion and triangulation in transgenic long-QT type 1 rabbits. PLoS One, 9, 2014, e107210, 10.1371/journal.pone.0107210.
140. Ziupa, D., Menza, M., Beck, J., Franke, G., Perez Feliz, S., Brunner, M., Koren, G., Zehender, M., Bode, C., Jung, B., Foell, D., Odening, K.E., E4031 affects regional electrical and diastolic function in transgenic LQT1 rabbits. Heart Rhythm. Suppl., 2013, A9010.
141. Ziv, O., Morales, E., Song, Y.K., Peng, X., Odening, K.E., Buxton, A.E., Karma, A., Koren, G., Choi, B.R., Origin of complex behaviour of spatially discordant alternans in a transgenic rabbit model of type 2 long QT syndrome. J. Physiol. 587 (2009), 4661–4680, 10.1113/jphysiol.2009.175018.